Holen Sie sich die Stockscreener-App
1.76
1.15%
0.02
Innate Pharma Adr-Aktien (IPHA) Preisverlauf
Täglich
Wöchentlich
Monatlich
7T
30T
60T
YTD
1J
| Datum | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2026-01-09 | $1.85 | $1.72 | $0.1296 | 10,580.0 | +1.15% |
| 2026-01-08 | $1.85 | $1.74 | $0.11 | 5,393.0 | -1.69% |
| 2026-01-07 | $1.83 | $1.74 | $0.0875 | 5,439.0 | +1.72% |
| 2026-01-06 | $1.86 | $1.74 | $0.12 | 37,906.0 | -1.69% |
| 2026-01-05 | $1.79 | $1.77 | $0.02 | 2,610.0 | -2.75% |
| 2026-01-02 | $1.85 | $1.82 | $0.03 | 16,631.0 | +4.00% |
| 2025-12-31 | $1.80 | $1.70 | $0.0999 | 15,348.0 | +0.57% |
| 2025-12-30 | $1.83 | $1.73 | $0.10 | 33,297.0 | +2.35% |
| 2025-12-29 | $1.77 | $1.70 | $0.075 | 31,725.0 | -2.86% |
| 2025-12-26 | $1.75 | $1.63 | $0.12 | 23,107.0 | +2.94% |
| 2025-12-24 | $1.76 | $1.66 | $0.10 | 37,422.0 | -3.41% |
| 2025-12-23 | $1.76 | $1.72 | $0.04 | 31,507.0 | -1.68% |
| 2025-12-22 | $1.81 | $1.70 | $0.11 | 36,311.0 | +2.29% |
| 2025-12-19 | $1.80 | $1.70 | $0.10 | 35,274.0 | -0.57% |
| 2025-12-18 | $1.81 | $1.64 | $0.17 | 92,431.0 | -2.76% |
| 2025-12-17 | $1.84 | $1.75 | $0.09 | 34,056.0 | -2.43% |
| 2025-12-16 | $1.94 | $1.81 | $0.13 | 43,121.0 | -1.33% |
| 2025-12-15 | $1.88 | $1.80 | $0.0799 | 21,284.0 | +1.08% |
| 2025-12-12 | $1.89 | $1.81 | $0.08 | 24,154.0 | +0.54% |
| 2025-12-11 | $1.91 | $1.85 | $0.055 | 5,873.0 | +0.00% |
Innate Pharma Adr-Aktien (IPHA) Preisverlauf Jahr für Jahr
In dieser detaillierten Analyse präsentieren wir einen umfassenden Überblick über die Kursbewegungen der Innate Pharma Adr-Aktie im Laufe der Jahre. Durch die Untersuchung der Jahresdaten können Investoren wertvolle Einblicke in die historische Performance und Volatilität der IPHA-Aktien gewinnen. Von bedeutenden Meilensteinen und Schwankungen bis hin zu bemerkenswerten Trends bietet diese gründliche Untersuchung der Preisgeschichte der Innate Pharma Adr-Aktie eine Grundlage für das Verständnis der Entwicklung der Aktien des Unternehmens im Laufe der Zeit.
Innate Pharma Adr-Aktien (IPHA) Preisverlauf 2026
| Monat | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2026-01 | $1.86 | $1.72 | $0.1396 | 89,139.0 | +0.57% |
Innate Pharma Adr-Aktien (IPHA) Preisverlauf 2025
| Monat | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2025-12 | $2.01 | $1.63 | $0.38 | 580,955.0 | -10.77% |
| 2025-11 | $2.42 | $1.73 | $0.695 | 11,186,797.0 | -1.02% |
| 2025-10 | $2.40 | $1.95 | $0.45 | 521,358.0 | +2.07% |
| 2025-09 | $2.19 | $1.77 | $0.42 | 420,683.0 | -10.65% |
| 2025-08 | $2.40 | $1.97 | $0.422 | 137,211.0 | +2.37% |
| 2025-07 | $2.63 | $1.70 | $0.93 | 267,703.0 | +16.25% |
| 2025-06 | $2.21 | $1.71 | $0.50 | 234,381.0 | -17.12% |
| 2025-05 | $2.56 | $2.02 | $0.54 | 615,976.0 | -1.79% |
| 2025-04 | $2.30 | $1.69 | $0.609 | 570,562.0 | +25.28% |
| 2025-03 | $2.18 | $1.77 | $0.41 | 318,967.0 | -16.04% |
| 2025-02 | $2.59 | $1.72 | $0.87 | 13,197,195.0 | +15.85% |
| 2025-01 | $1.95 | $1.60 | $0.35 | 995,756.0 | -0.54% |
Innate Pharma Adr-Aktien (IPHA) Preisverlauf 2024
| Monat | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2024-12 | $3.51 | $1.41 | $2.10 | 29,462,855.0 | +26.62% |
| 2024-11 | $2.06 | $1.29 | $0.77 | 230,065.0 | -18.56% |
| 2024-10 | $2.27 | $1.70 | $0.57 | 248,404.0 | -17.42% |
| 2024-09 | $2.41 | $2.07 | $0.333 | 159,360.0 | -0.22% |
| 2024-08 | $2.44 | $2.06 | $0.38 | 130,237.0 | +6.99% |
| 2024-07 | $2.38 | $1.99 | $0.39 | 133,518.0 | +10.57% |
| 2024-06 | $2.89 | $1.93 | $0.965 | 192,536.0 | -29.20% |
| 2024-05 | $3.05 | $2.31 | $0.7382 | 190,375.0 | +18.61% |
| 2024-04 | $3.15 | $2.25 | $0.90 | 239,160.0 | -19.79% |
| 2024-03 | $2.90 | $2.25 | $0.6498 | 230,630.0 | +9.92% |
| 2024-02 | $2.69 | $2.32 | $0.37 | 122,336.0 | -2.24% |
| 2024-01 | $3.07 | $2.49 | $0.5804 | 288,903.0 | -4.29% |
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):